Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Toronto

$135,000.00

Novel structural approaches towards a better understanding of HIV integrase, the architect of viral persistence in human cells

FY 2015-16

Summary
The human immune deficiency virus (HIV) is the causative agent of acquired immunodeficiency syndrome (AIDS). Despite advances in therapy, HIV infection remains incurable. The process of integration, catalyzed by HIV integrase protein, inserts the viral DNA into human chromosomal DNA and is responsible for HIV persistence even after suppressive therapy. This make integrase a vital drug target, and recently approved integrase inhibitors have become a critical part of antiviral therapy. The latest inhibitor, dolutegravir, is the most potent drug discovered to date and a frontline component in antiretroviral cocktails. The mechanisms of HIV integration have been aided by crystal structures of prototype foamy virus (PFV) integrase, but due to differences between PFV and HIV biology, these structures cannot explain the interaction of HIV integrase with cofactor proteins or the unusual resistance profile of dolutegravir. This study will attempt to obtain a full-length structure of HIV integrase by engineering, characterizing, and crystallizing chimeric structures of PFV and HIV integrase. The use of chimeras takes advantage of the favorable crystallization characteristics of PFV integrase, but maintains the functional features of HIV integrase. The structural data obtained will be first in-class to serve as models to better understand the mechanisms of HIV DNA integration. It will likely lead to the discovery of important information for the design of new IN drugs that are less prone to resistance and open up new avenues of research.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
338917
Name
Quashie Peter K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Novel structural approaches towards a better understanding of HIV integrase, the architect of viral persistence in human cells
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Biophysical Characterization; Crystallography; Hiv/Aids; Protein Dna Binding; Protein Engineering; Protein Structure; Protein:Protein Interactions; Saxs
Abstract
The human immune deficiency virus (HIV) is the causative agent of acquired immunodeficiency syndrome (AIDS). Despite advances in therapy, HIV infection remains incurable. The process of integration, catalyzed by HIV integrase protein, inserts the viral DNA into human chromosomal DNA and is responsible for HIV persistence even after suppressive therapy. This make integrase a vital drug target, and recently approved integrase inhibitors have become a critical part of antiviral therapy. The latest inhibitor, dolutegravir, is the most potent drug discovered to date and a frontline component in antiretroviral cocktails. The mechanisms of HIV integration have been aided by crystal structures of prototype foamy virus (PFV) integrase, but due to differences between PFV and HIV biology, these structures cannot explain the interaction of HIV integrase with cofactor proteins or the unusual resistance profile of dolutegravir. This study will attempt to obtain a full-length structure of HIV integrase by engineering, characterizing, and crystallizing chimeric structures of PFV and HIV integrase. The use of chimeras takes advantage of the favorable crystallization characteristics of PFV integrase, but maintains the functional features of HIV integrase. The structural data obtained will be first in-class to serve as models to better understand the mechanisms of HIV DNA integration. It will likely lead to the discovery of important information for the design of new IN drugs that are less prone to resistance and open up new avenues of research.
Competitiondate
201511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Quashie, Peter K
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~
University of Toronto - $135,000 Grant (2015-16) | Canada Spends